AstraZeneca halts key lung cancer trial after setback
TimesLive | 17.08.2026 15:58
AstraZeneca is discontinuing a late-stage trial that tested the experimental drug volrustomig plus chemotherapy in patients with metastatic non-small cell lung cancer, it said on Monday, extending a run of setbacks that has deepened scrutiny of the drugmaker’s development pipeline.
